The Claim
Semaglutide initiation is associated with modest reductions in systolic blood pressure by 1.1 mm Hg and diastolic blood pressure by 1.5 mm Hg over a period of 13 to 24 months in adults.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Adults who start taking semaglutide experience a small decrease in both systolic and diastolic blood pressure over 13 to 24 months.
See the scientific wording
Semaglutide initiation is associated with modest reductions in systolic and diastolic blood pressure (−1.1 mm Hg and −1.5 mm Hg, respectively) over 13 to 24 months in adults, suggesting a potential association between semaglutide use and improved cardiovascular risk profiles.
Semaglutide causes the kidneys to remove more salt and water from the blood, which lowers blood volume, and it also makes blood vessels relax, which reduces resistance to blood flow.
What the research says
1 studyPeople who started taking semaglutide had slightly lower blood pressure after a year and a half—by about 1 point on both numbers—which is a small but real change that might help their heart health.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.